Literature DB >> 15034129

Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum.

H Daniel1, A Rancillac, F Crepel.   

Abstract

Activation of CB1 cannabinoid receptors in the cerebellum acutely depresses excitatory synaptic transmission at parallel fibre-Purkinje cell synapses by decreasing the probability of glutamate release. This depression involves the activation of presynaptic 4-aminopyridine-sensitive K(+) channels by CB1 receptors, which in turn inhibits presynaptic Ca(2+) influx controlling glutamate release at these synapses. Using rat cerebellar frontal slices and fluorometric measures of presynaptic Ca(2+) influx evoked by stimulation of parallel fibres with the fluorescent dye fluo-4FF, we tested whether the CB1 receptor-mediated inhibition of this influx also involves a direct inhibition of presynaptic voltage-gated calcium channels. Since various physiological effects of CB1 receptors appear to be mediated through the activation of PTX-sensitive proteins, including inhibition of adenylate cyclases, activation of mitogen-activated protein kinases (MAPK) and activation of G protein-gated inwardly rectifying K(+) channels, we also studied the potential involvement of these intracellular signal transduction pathways in the cannabinoid-mediated depression of presynaptic Ca(2+) influx. The present study demonstrates that the molecular mechanisms underlying the CB1 inhibitory effect involve the activation of the PTX-sensitive G(i)/G(o) subclass of G proteins, independently of any direct effect on presynaptic Ca(2+) channels (N, P/Q and R (SNX-482-sensitive) types) or on adenylate cyclase or MAPK activity, but do require the activation of G protein-gated inwardly rectifying (Ba(2+)- and tertiapin Q-sensitive) K(+) channels, in addition to 4-aminopyridine-sensitive K(+) channels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034129      PMCID: PMC1665033          DOI: 10.1113/jphysiol.2004.063263

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  60 in total

1.  Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.

Authors:  M Glass; C C Felder
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

2.  Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A.

Authors:  M Jung; R Calassi; M Rinaldi-Carmona; P Chardenot; G Le Fur; P Soubrié; F Oury-Donat
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

Review 3.  Presynaptic inhibition of elicited neurotransmitter release.

Authors:  L G Wu; P Saggau
Journal:  Trends Neurosci       Date:  1997-05       Impact factor: 13.837

4.  Synthesis of a stable form of tertiapin: a high-affinity inhibitor for inward-rectifier K+ channels.

Authors:  W Jin; Z Lu
Journal:  Biochemistry       Date:  1999-10-26       Impact factor: 3.162

Review 5.  Role of cyclic AMP in the actions of cannabinoid receptors.

Authors:  S R Childers; S A Deadwyler
Journal:  Biochem Pharmacol       Date:  1996-09-27       Impact factor: 5.858

6.  Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.

Authors:  W Twitchell; S Brown; K Mackie
Journal:  J Neurophysiol       Date:  1997-07       Impact factor: 2.714

7.  Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.

Authors:  S D McAllister; G Griffin; L S Satin; M E Abood
Journal:  J Pharmacol Exp Ther       Date:  1999-11       Impact factor: 4.030

8.  Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons.

Authors:  J M Sullivan
Journal:  J Neurophysiol       Date:  1999-09       Impact factor: 2.714

9.  Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices.

Authors:  Y P Maneuf; J M Brotchie
Journal:  Br J Pharmacol       Date:  1997-04       Impact factor: 8.739

10.  PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.

Authors:  D R Alessi; A Cuenda; P Cohen; D T Dudley; A R Saltiel
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157

View more
  17 in total

1.  D1-like dopamine receptors selectively block P/Q-type calcium channels to reduce glutamate release onto cholinergic basal forebrain neurones of immature rats.

Authors:  Toshihiko Momiyama; Yugo Fukazawa
Journal:  J Physiol       Date:  2007-01-18       Impact factor: 5.182

2.  A new signalling pathway for parallel fibre presynaptic type 4 metabotropic glutamate receptors (mGluR4) in the rat cerebellar cortex.

Authors:  Karine Abitbol; Heather McLean; Thomas Bessiron; Hervé Daniel
Journal:  J Physiol       Date:  2012-05-08       Impact factor: 5.182

3.  In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors.

Authors:  Shivani Sachdev; Kiran Vemuri; Samuel D Banister; Mitchell Longworth; Michael Kassiou; Marina Santiago; Alexandros Makriyannis; Mark Connor
Journal:  Br J Pharmacol       Date:  2019-12-10       Impact factor: 8.739

Review 4.  Cannabinoids in the descending pain modulatory circuit: Role in inflammation.

Authors:  Courtney A Bouchet; Susan L Ingram
Journal:  Pharmacol Ther       Date:  2020-01-29       Impact factor: 12.310

5.  Alterations in the intrinsic burst activity of Purkinje neurons in offspring maternally exposed to the CB1 cannabinoid agonist WIN 55212-2.

Authors:  Mohammad Shabani; Amin Mahnam; Vahid Sheibani; Mahyar Janahmadi
Journal:  J Membr Biol       Date:  2013-11-12       Impact factor: 1.843

Review 6.  Chemical calcium indicators.

Authors:  R Madelaine Paredes; Julie C Etzler; Lora Talley Watts; Wei Zheng; James D Lechleiter
Journal:  Methods       Date:  2008-10-16       Impact factor: 3.608

7.  Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat.

Authors:  Hassan Abbassian; Benjamin J Whalley; Vahid Sheibani; Mohammad Shabani
Journal:  Br J Pharmacol       Date:  2016-10-04       Impact factor: 8.739

Review 8.  Presynaptic long-term depression mediated by Gi/o-coupled receptors.

Authors:  Brady K Atwood; David M Lovinger; Brian N Mathur
Journal:  Trends Neurosci       Date:  2014-08-24       Impact factor: 13.837

9.  Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha.

Authors:  Vivien Chevaleyre; Boris D Heifets; Pascal S Kaeser; Thomas C Südhof; Dominick P Purpura; Pablo E Castillo
Journal:  Neuron       Date:  2007-06-07       Impact factor: 17.173

10.  Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning.

Authors:  Patrick D Skosnik; Chad R Edwards; Brian F O'Donnell; Ashley Steffen; Joseph E Steinmetz; William P Hetrick
Journal:  Neuropsychopharmacology       Date:  2007-07-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.